154 related articles for article (PubMed ID: 32684846)
1. Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma.
Huang W; Zhang Y; Xu Y; Yang S; Li B; Huang L; Lou G
Cancer Cell Int; 2020; 20():309. PubMed ID: 32684846
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expressions of PURPL, miR-363-3p and ADAM10 predicted poor prognosis for patients with ovarian serous cystadenocarcinoma.
Zhang R; Guo X; Zhao L; He T; Feng W; Ren S
J Cancer; 2023; 14(15):2908-2918. PubMed ID: 37781085
[No Abstract] [Full Text] [Related]
3. Prognostic Role of Zinc Finger Homeobox 4 in Ovarian Serous Cystadenocarcinoma.
Ha M; Kim J; Park SM; Hong CM; Han ME; Song P; Kang CD; Lee D; Kim YH; Hur J; Oh SO
Genet Test Mol Biomarkers; 2020 Mar; 24(3):145-149. PubMed ID: 32105524
[No Abstract] [Full Text] [Related]
4. [Bioinformatics analysis of the association between long non-coding RNA ubiquitin-specific peptidase 30 antisense RNA 1 (lncRNA USP30-AS1) and immune cell infiltration in ovarian serous cystadenocarcinoma].
Wang H; Huang S; Meng Q; Zhang J; Wei L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Sep; 39(9):834-840. PubMed ID: 37732580
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of a prognostic index based on a metabolic-genomic landscape analysis of ovarian cancer.
Zhang QF; Li YK; Chen CY; Zhang XD; Cao L; Quan FF; Zeng X; Wang J; Liu J
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32880385
[TBL] [Abstract][Full Text] [Related]
6. Expression of Inorganic Pyrophosphatase (PPA1) Correlates with Poor Prognosis of Epithelial Ovarian Cancer.
Li H; Xiao N; Li Z; Wang Q
Tohoku J Exp Med; 2017 Feb; 241(2):165-173. PubMed ID: 28202851
[TBL] [Abstract][Full Text] [Related]
7. Low expression of acyl-CoA thioesterase 13 is associated with poor prognosis in ovarian serous cystadenocarcinoma.
Lv X; Wang W; Liu X; Liu Y; Guo L; Wang C
Front Genet; 2023; 14():1213022. PubMed ID: 37424730
[No Abstract] [Full Text] [Related]
8. MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma.
Yu X; Zhang X; Bi T; Ding Y; Zhao J; Wang C; Jia T; Han D; Guo G; Wang B; Jiang J; Cui S
Tumour Biol; 2013 Dec; 34(6):3501-8. PubMed ID: 23836287
[TBL] [Abstract][Full Text] [Related]
9. Identification of a 3-mRNA signature as a novel potential prognostic biomarker in patients with ovarian serous cystadenocarcinoma in G2 and G3.
Zhou J; Yi Y; Wang C; Su C; Luo Y
Oncol Lett; 2019 Oct; 18(4):3545-3552. PubMed ID: 31579405
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma.
He Y; Zeng S; Hu S; Zhang F; Shan N
Front Genet; 2020; 11():584624. PubMed ID: 33193718
[TBL] [Abstract][Full Text] [Related]
11. A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma.
Guo W; Zhu L; Yu M; Zhu R; Chen Q; Wang Q
Clin Epigenetics; 2018 Nov; 10(1):142. PubMed ID: 30446011
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a novel anoikis-related signature for predicting prognosis and immune landscape in ovarian serous cystadenocarcinoma.
Zhu YT; Wu SY; Yang S; Ying J; Tian L; Xu HL; Zhang HP; Yao H; Zhang WY; Jin QQ; Yang YT; Jiang XY; Zhang N; Yao S; Zhou SG; Chen G
Heliyon; 2023 Aug; 9(8):e18708. PubMed ID: 37554782
[TBL] [Abstract][Full Text] [Related]
13. Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma.
Zhang J; Li Y; Fan TY; Liu D; Zou WD; Li H; Li YK
Front Oncol; 2022; 12():1021558. PubMed ID: 36276071
[TBL] [Abstract][Full Text] [Related]
14. Zinc Finger Protein 24 is a Prognostic Factor in Ovarian Serous Carcinoma.
Chen J; Guo J; Yuan Y; Wang Y
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):136-144. PubMed ID: 34608874
[TBL] [Abstract][Full Text] [Related]
15. Expression of EphB6 in ovarian serous carcinoma is associated with grade, TNM stage and survival.
Gu Y; Li F; Qian N; Chen X; Wang H; Wang J
J Clin Pathol; 2016 May; 69(5):448-53. PubMed ID: 26468391
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf-1 is frequently overexpressed in ovarian serous carcinoma and involved in tumor invasion.
Wang S; Zhang S
Clin Exp Metastasis; 2011 Aug; 28(6):581-91. PubMed ID: 21607803
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer.
Paik ES; Kim JH; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
J Gynecol Oncol; 2018 Jan; 29(1):e13. PubMed ID: 29185271
[TBL] [Abstract][Full Text] [Related]
18. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ICAM-1 Predicts Poor Survival in High-Grade Serous Ovarian Carcinoma: A Study Based on TCGA and GEO Databases and Tissue Microarray.
Wang S; Yin C; Zhang Y; Zhang L; Tao L; Liang W; Pang L; Fu R; Ding Y; Li F; Jia W
Biomed Res Int; 2019; 2019():2867372. PubMed ID: 31312656
[TBL] [Abstract][Full Text] [Related]
20. Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma.
Ren X; Wang X; Peng B; Liang Q; Cai Y; Gao K; Hu Y; Xu Z; Yan Y
Int J Gen Med; 2021; 14():7133-7143. PubMed ID: 34737608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
